Skip to main content
. 2018 Dec 11;37:306. doi: 10.1186/s13046-018-0983-0

Fig. 6.

Fig. 6

Biologic characterization of TRNT with 131I-5-IPN in B16F10 model. a Immunofluorescence staining for CD31 (vascularity) and Ki67 (proliferation) in tumors 24 h and 12 d after TRNT (× 200). b and c The amount of CD31 expression and Ki67 expression quantified from immunofluorescence staining of treated and control tumors (***P < 0.0001)